Steven Cohen Lannett CO Inc Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $167,850 - $512,386	-35,337 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $715,890 - $1.22 Million	-48,700 Reduced 57.95%	35,337 $567,000
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $1.67 Million - $2.46 Million	84,037	84,037 $1.95 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.